NOVUHAIR Supports Alopecia Philippines
September 2020 marks the seven (7) fruitful years of collaboration between NOVUHAIR®, the leading hair loss treatment in the country and THE ALOPECIA PHILIPPINES, a
September 2020 marks the seven (7) fruitful years of collaboration between NOVUHAIR®, the leading hair loss treatment in the country and THE ALOPECIA PHILIPPINES, a
Hair loss may be a common thing, but there is still a long list of myths surrounding it, most of which you can find online.
Male pattern baldness, medically known as androgenic alopecia, is the most common type of hair loss in men. It is usually caused by a combination
ADP Pharma Corporation is celebrating its 10th year anniversary. This video showcases milestones that ADP achieved throughout the years. The company established its position in
Copyright 2020 © Novuhair.com | All rights reserved.
NOVUHAIR® is clinically proven effective and safe. Food and Drug Administration (FDA) registered and 100% compliant to the ASEAN Cosmetic Directive (ACD).